AA
Ainsley Mike Antao
Cancer Research UK Scotland Institute, Columbia University, Syngene International Ltd
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Ubiquitin and proteasome pathways · Pluripotent Stem Cells Research · Mesenchymal stem cell research
Employment
-
CRUK Scotland Institute Translational Scientist2024 - Present
-
Columbia University Postdoctoral Research Scientist2022 - 2024
-
Syngene International Ltd2016 - 2018
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer Save
- An Efficient Endothelial Cell Differentiation Protocol Using Bioactive Lipid O-Cyclic Phytosphingosine-1-Phosphate in Human Embryonic Stem Cells Save
- A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer Save
- USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression. Save
- USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B Save
- Bioactive lipid o-cyclic phytosphingosine-1-phosphate promotes differentiation of human embryonic stem cells into cardiomyocytes via alk3/bmpr signaling Save
- CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals Save
- The Role of Nkx3.1 in Cancers and Stemness Save
- Ubiquitin‐specific protease 3 deubiquitinates and stabilizes oct4 protein in human embryonic stem cells Save
- Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics Save
- Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems Save
- E3 ubiquitin ligase apc/ccdh1 regulation of phenylalanine hydroxylase stability and function Save
- Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy Save